Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Hung C Tran, Zesheng Wan, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Journal of Neuro-Oncology
|
February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
Nathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.
Experimental Cell Research
|
April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration
Michael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.
Scientific Reports
|
November 14, 2023
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma
Danny Lascano, Michael J Zobel, William G Lee, et al.
Oncoimmunology
|
January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
Soheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Oncotarget
|
December 7, 2017
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
Michael D Hadjidaniel, Sakunthala Muthugounder, Long T Hung, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Hung C Tran, Zesheng Wan, Michael A Sheard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Journal of Neuro-Oncology
|
February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors
Nathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.
Experimental Cell Research
|
April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration
Michael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.
Scientific Reports
|
November 14, 2023
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma
Danny Lascano, Michael J Zobel, William G Lee, et al.
Oncoimmunology
|
January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
Soheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Oncotarget
|
December 7, 2017
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
Michael D Hadjidaniel, Sakunthala Muthugounder, Long T Hung, et al.
Page
of 5